Tibet Rhodiola Pharmaceutical Holding Co Cash Flow Quality Index
Tibet Rhodiola Pharmaceutical Holding Co cash flow quality index. Tibet Rhodiola Pharmaceutical Holding Co (600211) has a Cash Flow Quality Index of 1.38x as of December 2025. Operating cash flow of CN¥297.86 Million exceeds net income of CN¥216.15 Million, indicating high earnings quality where cash backs reported profits. See Tibet Rhodiola Pharmaceutical Holding Co (600211) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Tibet Rhodiola Pharmaceutical Holding Co (1999–2025)
Cash flow quality index of Tibet Rhodiola Pharmaceutical Holding Co from 1999 to 2025. Historical Cash Flow Quality Index for Tibet Rhodiola Pharmaceutical Holding Co across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Tibet Rhodiola Pharmaceutical Holding Co (600211) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Tibet Rhodiola Pharmaceutical Holding Co Cash Flow Quality Index by Year (1999–2025)
Tibet Rhodiola Pharmaceutical Holding Co cash flow quality index by year from 1999 to 2025. Year-by-year earnings quality comparison for Tibet Rhodiola Pharmaceutical Holding Co. For the full cash flow conversion analysis, see cash flow conversion of Tibet Rhodiola Pharmaceutical Holding Co.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.09x | CN¥1.03 Billion | CN¥937.93 Million | ▲ +16.3% |
| 2024 | 0.94x | CN¥994.79 Million | CN¥1.06 Billion | ▼ -30.3% |
| 2023 | 1.35x | CN¥1.08 Billion | CN¥800.91 Million | ▼ -39.4% |
| 2022 | 2.23x | CN¥837.38 Million | CN¥375.28 Million | ▲ +29.7% |
| 2021 | 1.72x | CN¥366.53 Million | CN¥213.03 Million | ▲ +69.0% |
| 2020 | 1.02x | CN¥428.17 Million | CN¥420.66 Million | ▼ -34.0% |
| 2019 | 1.54x | CN¥489.59 Million | CN¥317.37 Million | ▲ +16.3% |
| 2018 | 1.33x | CN¥289.22 Million | CN¥218.09 Million | ▲ +239.7% |
| 2017 | 0.39x | CN¥91.46 Million | CN¥234.29 Million | ▼ -68.9% |
| 2016 | 1.25x | CN¥250.21 Million | CN¥199.40 Million | ▼ -15.0% |
| 2015 | 1.48x | CN¥133.93 Million | CN¥90.74 Million | ▲ +121.1% |
| 2014 | -7.00x | CN¥-141.40 Million | CN¥20.21 Million | ▼ -160.0% |
| 2013 | 11.65x | CN¥279.22 Million | CN¥23.96 Million | ▲ +532.5% |
| 2012 | 1.84x | CN¥56.20 Million | CN¥30.50 Million | ▲ +221.3% |
| 2011 | 0.57x | CN¥12.09 Million | CN¥21.09 Million | ▲ +629.7% |
| 2010 | 0.08x | CN¥1.90 Million | CN¥24.18 Million | ▼ -90.8% |
| 2009 | 0.86x | CN¥17.88 Million | CN¥20.84 Million | ▼ -76.6% |
| 2008 | 3.66x | CN¥21.46 Million | CN¥5.86 Million | ▼ -73.3% |
| 2006 | 13.70x | CN¥33.63 Million | CN¥2.46 Million | ▲ +205.3% |
| 2004 | 4.49x | CN¥26.90 Million | CN¥6.00 Million | ▼ -45.9% |
| 2003 | 8.30x | CN¥47.20 Million | CN¥5.69 Million | ▲ +156.3% |
| 2002 | 3.24x | CN¥32.85 Million | CN¥10.14 Million | ▲ +281.7% |
| 2001 | 0.85x | CN¥15.47 Million | CN¥18.24 Million | ▲ +47.5% |
| 2000 | 0.58x | CN¥20.55 Million | CN¥35.72 Million | ▲ +747.0% |
| 1999 | 0.07x | CN¥2.25 Million | CN¥33.08 Million | — |